Bristol-Myers pays $30 million to settle kickback charges
(By Ed Silverman for STAT) After nearly a decade of litigation, Bristol-Myers Squibb on Monday agreed to pay $30 million
Read More
Legislative Update
FDA Sanctions Off-Label Drug Promotion
(By Deborah Mazer and Gregory Curfman, for Health Affairs Blog, July 19, 2016) Physicians have the authority to prescribe drugs
Read MoreUnspent Dollars
On Thursday, six leading republicans in Congress wrote to President Obama questioning why the White House has not released the
Read MoreSenate sends first major opioids legislation to Obama’s desk
(By Dylan Scott for STAT) WASHINGTON — The first major legislation to address the growing crisis of opioid addiction is
Read MoreSenate delays Cures bill, as window for major legislation narrows
(By David Nather for STAT) WASHINGTON — Lawmakers are officially giving up hopes of considering a bill to speed the development of
Read MoreFDA narrowly defines the ability of compounders to make approved medicines
(By Ed Silverman for STAT) In its latest to bid to set parameters around compounding, the US Food and Drug
Read MoreHouse Panel Extends Funding For Medicare Program To Help Consumers
(By Susan Jaffe for Kaiser Health News) A House subcommittee voted on Thursday to continue $52 million in funding for
Read MoreH.R. 2646 Passed the House
On Wednesday, the House overwhelmingly passed bill H.R. 2646: Helping Families in Mental Health Crisis Act of 2015. Read article
Read MoreHHS announces new actions to combat opioid epidemic
(Source – www.hhs.gov) U.S. Health and Human Services (HHS) Secretary Sylvia M. Burwell today announced several new actions the department
Read More5 Myths About FDA’s Regulation of Vapor Products
(By Elaine Keller for The Daily Signal) On May 5, the U.S. Food and Drug Administration finalized a rule known
Read More